American Cancer Society. Cancer Facts and Figures-1995. Atlanta, GA (USA): American Cancer Society, 1995.
Thomas DB. Oral contraceptives and breast cancer: Review of the epidemiologic literature. Contraception 1991; 43: 597–642.
Romieu I, Berlin JA, Colditz GA. Oral contraceptives and breast cancer: Review and meta-analysis. Cancer 1990; 66: 2253–63.
Malone KE, Daling JR, Weiss NS, et al. Oral contraceptives in relation to breast cancer. Epidemiol Rev 1993; 15: 80–97.
Brinton LA, Daling JR, Gammon MD, Hanson L, Hoover RN. Oral contraceptives and breast cancer risk among younger women. JNCI 1995; 87: 827–35.
White E, Malone KE, Weiss NS, Daling JR. Breast cancer among young U.S. women in relation to oral contraceptive use. JNCI 1994; 86: 505–14.
Rosenberg L, Palmer JR, Rao RS, et al. Case-control study of oral contraceptive use and risk of breast cancer. Am J Epidemiol 1996; 143: 25–37.
Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet 1996; 347: 1713–27.
Romieu I, Willett WC, Colditz GA, et al. Prospective study of oral contraceptive use and risk of breast cancer in women. JNCI 1989; 81: 1313–21.
Colditz GA, Stampfer MJ, Willett WC, et al. Reproduci-bility and validity of self-reported menopausal status in a prospective cohort of women. Am J Epidemiol 1987; 126: 319–25.
Willett WC, Sampson L, Stampfer MJ, et al. Reproducibil-ity and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985; 122: 51–65.
Willett W, Sampson L, Browne ML, et al. The use of a self-administered questionnaire to assess diet four years in the past. Am J Epidemiol 1988; 127: 188–99.
Giovannucci E, Colditz GA, Stampfer MJ, et al. The assessment of alcohol consumption by a simple self-admin-istered questionnaire. Am J Epidemiol 1991; 133: 810–7.
Stampfer MJ, Willett WC, Speizer FE, et al. Test of the National Death Index. Am J Epidemiol 1984; 119: 837–9.
Rich-Edwards JW, Corsano KA, Stampfer MJ. Test of the National Death Index and Equifax Nationwide Death Search. Am J Epidemiol 1994; 140: 1016–9.
Miettinen O. Estimability and estimation in case-referent studies. Am J Epidemiol 1976; 103: 226–35.
Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic Research: Principles and Quantitative Methods. Belmont, CA (USA): Lifetime Learning, 1982.
Cox DR. Regression models and life-tables. J R Stat Soc 1972; 32: 187–220.
D'Agostino RB, Lee ML, Belanger AJ, Cupples LA, Anderson K, Kannel WB. Relation of pooled logistic regression to time dependent Cox regression analysis: The Framingham Heart Study. Stat Med 1990; 9: 1501–15.
Hankinson SE, Colditz GA, Hunter DJ, et al. A prospective study of reproductive factors and risk of epithelial ovarian cancer. Cancer 1995; 76: 284–90.
Stampfer MJ, Goldhaber SZ, Manson JE, et al. A prospec-tive study of exogenous hormones and risk of pulmonary embolism in women [Abstract]. Circulation 1992; 86(Suppl 1): 2689.
Harris JR, Lippman ME, Veronsei U, Willett WC. Breast cancer. N Engl J Med (3 parts) 1992; 327: 319–28, 390–8, 473–80.
Anderson TJ, Battersby S, King RJB, McPherson K, Going JJ. Oral contraceptive use influences resting breast prolif-eration. Hum Pathol 1989; 20: 1139–44.
Williams G, Anderson E, Howell A, et al. Oral contracep-tive (OCP) use increases proliferation and decreases oestrogen receptor content of epithelial cells in the normal human breast. Int J Cancer 1991; 48: 206–10.
Anderson TJ, Battersby S, King RJB, McPherson K. Breast epithelial responses and steroid receptors during oral con-traceptive use. In: Mann RD, ed. Oral Contraceptives and Breast Cancer. ParkRidge, New Jersey (USA): Parthenon Publishing Group,1990.
Institute of Medicine. Oral Contraceptives and Breast Cancer. Washington DC: National Academy Press, 1991.
Selby C. Sex hormone binding globulin: origin, function and clinical significance. Ann Clin Biochem 1990; 27: 532–41.
Annegers JF. Patterns of oral contraceptive use in the United States. Br J Rheumatology 1989; 28: 48–50.
Piper JM, Kennedy DL. Oral contraceptives in the United States: Trends in content and potency. Int J Epidemiol 1987; 16: 215–21.
Rookus MA, van Leeuwen FE, for the Netherlands Oral Contraceptives and Breast Cancer Study Group. Oral contraceptives and risk of breast cancer in women aged 20–54 years. Lancet 1994; 344: 844–51.
Ewertz M. Oral contraceptives and breast cancer risk in Denmark. Eur J Cancer 1992; 28A: 1176–81.
Vessey MP. Results from the Oxford-Family Planning Association Study. In: Mann, RD, ed. Oral Contraceptives and Breast Cancer. Park Ridge, NJ (USA): Parthenon Pub-lishing Group, 1990; 271–84.
Vessey MP, McPherson K, Villard-Mackintosh L, Yeates D. Oral contraceptives and breast cancer: latest finding in a large cohort study. Br J Cancer 1989; 59: 613–7.
Kay CR, Hannaford PC. Breast cancer and the pill-A further report from the Royal College of General Practi-tioners' oral contraceptive study. Br J Cancer 1988; 58: 675–80.
UK National Case-Control Study Group. Oral contracep-tive use and breast cancer risk in young women. Lancet 1989; i: 973–82.
McPherson K, Vessey MP, Neil A, Doll R, Jones L, Roberts M. Early oral contraceptive use and breast cancer: results of another case-control study. Br J Cancer 1987; 56: 653–60.
Skegg DCG. Potential bias in case-control studies of oral contraceptives and breast cancer. Am J Epidemiol 1988; 127: 205–12.
Paul C, Skegg DCG, Spears GFS. Oral contraceptives and risk of breast cancer. Int J Cancer 1990; 46: 366–73.